Advertisement

Product › Details
Genedata Selector® for TLA Data Analysis
![]() |
Next higher product group | genomic software tools_o |
![]() |
Status | 2020-04-28 sales start |
![]() |
Organisation | Genedata AG |
Group | Danaher (Group) | |
Genedata AG. (4/28/20). "Press Release: Genedata Partners with Cergentis to Provide End-to-end Solution for Automating TLA-based Clone Selection". Basel.
Genedata Selector automates sample management, data analysis and report generation for high-throughput Targeted Locus Amplification (TLA) workflow
Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced the availability of Genedata Selector® for automating the Targeted Locus Amplification (TLA) data analysis workflow. The software solution is the result of a close collaboration with Cergentis, an innovative leader in the genomics space and the developer and provider of the TLA technology, together with joint customers in the biopharmaceutical industry.
The cutting-edge TLA technology is used during cell line development to standardize and speed up the clone selection process. With TLA, Cergentis provides a cost-efficient, high resolution technology to determine transgene integration sites and detect single nucleotide and structural variants in the transgene sequence, as well as structural changes in and surrounding transgene sequences. This information is highly relevant to quickly assess the quality of cell line clones during cell line development. TLA also detects sequence changes resulting from targeted genome editing (such as CRISPR) and/or targeted transgene integrations.
As the technology is now being implemented in many biopharmaceutical R&D organizations to speed and scale up the experimental throughput, the need has emerged for a scalable computational solution that allows customers to rapidly analyze their own TLA data to accelerate decision making during the cell line development process. Besides scalability, key requirements for such a computational solution are workflow integration from sample registration to reporting, plus ease of use from the perspective of a scientist.
Genedata Selector is the first-in-class software platform that satisfies these key requirements. Providing an end-to-end solution, it offers sample registration capabilities and includes the option of full automation of the highly complex sequence data analysis process. Intuitive visualizations enable quick decision making and can be easily integrated into reports used for regulatory purposes.
Highly cost- and time-efficient, Genedata Selector:
> offers full automation of the data analysis workflow, speeds up complex analysis workflows, enables high experimental throughput, and delivers data analysis results without the need for special data analysis expertise;
> maintains a full track record of analyzed clones, including clone hierarchies, with audit trail functionality that allows deployment in a regulatory-compliant environment;
> reduces by orders of magnitude the analysis time from project initiation to reporting of results;
> can be deployed on premises as well as under a Managed SaaS model.
“Genedata developed a push button system including a fully integrated analysis pipeline, to allow our customers in cell line development to get a comprehensive analysis report, including visual representation of integration sites,” said Max van Min, Founding Director of Cergentis. “Our customers now have available a computational platform that supports our market-leading TLA technology and enables them to significantly increase the number of clones analyzed, thereby increasing the efficiency of their quality control and cell line development workflow.”
“We are very pleased with our collaboration with Cergentis, a highly innovative company providing services and kits to improve the efficiency of cell line development. With Genedata Selector we now provide a solution that fully supports the deployment of their TLA technology,” said Othmar Pfannes, Ph.D., Founder and CEO of Genedata. “TLA, together with Genedata Selector, enables our customers to scale up their cell line development processes and generate results of the highest quality. This is another example of how Genedata—together with other technology leaders—supports our customers in the biopharma industry to increase the efficiency of R&D.”
About Genedata
Genedata transforms data into intelligence with innovative software solutions and domain-specific consulting services that automate complex, large-scale experimental processes and enable organizations to maximize the ROI in their R&D, spanning early discovery all the way to the clinic. Founded in 1997, Genedata is headquartered in Switzerland with additional offices in Germany, Japan, Singapore, the UK, and the US.
www.genedata.com
LinkedIn | Twitter | YouTube
Disclaimer
The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company's products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
All product and service names mentioned are the trademarks of their respective companies.
Press Contact
Miles Fisher-Pollard
Public Relations
+41 61 511 85 61
[email protected]
Record changed: 2020-05-15 |
Advertisement

More documents for genomic software tools_o
- [1] Miltenyi Biotec B.V. & Co. KG. (4/29/24). "Press Release: Miltenyi Biotec and MiLaboratories Announce Strategic Partnership to Advance Next-generation Therapies". Bergisch Gladbach & San Francisco, CA....
- [2] Qiagen N.V.. (9/11/23). "Press Release: Qiagen Launches API to Streamline Access to World-leading Biomedical Data for AI Integration". Venlo & Redwood City, CA....
- [3] Sophia Genetics S.A.. (8/22/23). "Press Release: Sophia Genetics Expands Relationship with Gustave Roussy". Boston, MA & Rolle....
- [4] Sophia Genetics S.A.. (7/19/23). "Press Release: Sophia Genetics Supports Sofiva Genomics to Launch New HRD Test". Boston, MA & Rolle....
- [5] Qiagen N.V.. (6/13/23). "Press Release: Danish National Genome Center Selects Qiagen for Variant Interpretation in Oncology Genome Sequencing". Venlo & Redwood City, CA....
- [6] Sophia Genetics S.A.. (5/31/23). "Press Release: Sophia Genetics Announces Nomination of Lila Tretikov to Board of Directors". Boston, MA & Lausanne....
- [7] Qiagen N.V.. (1/23/23). "Press Release: Qiagen Digital Insights Launches Ultra-fast NGS Analysis Able to Process a Whole Genome in 25 Minutes for a $1 in Cloud Computing Costs". Redwood City, CA & Hilden....
- [8] Sophia Genetics S.A.. (7/22/21). "Press Release: Sophia Genetics Announces Pricing of Initial Public Offering". Boston, MA & Lausanne....
- [9] 10x Genomics, Inc.. (2/24/21). "Press Release: 10x Genomics Showcases Next Wave of Innovations at First Ever Xperience Event. Acquires Tetramer Shop, Reveals Details on Upcoming Products". Pleasanton, CA....
- [10] Sophia Genetics S.A.. (2/11/21). "Press Release: Sophia Genetics Appoints Ross Muken as Chief Financial Officer". Boston, MA & Lausanne....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement

» top